Who is sponsoring NCT04597515?

NCT04597515 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT04597515?

Interventions in NCT04597515: Robot Breast reduction surgery.

What condition does NCT04597515 study?

NCT04597515 studies Breast Hypertrophy.

Is NCT04597515 still recruiting?

NCT04597515 is currently status unknown. Last updated 22 October 2020.

Last reviewed 2020-10-22 · How we verify

NCT04597515: R-HTM-R

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reduction of Breast Enlargement Using the Da Vinci Xi Robot

Status unknown NA Last updated 22 October 2020

What this trial tests

NA trial testing Robot Breast reduction surgery in Breast Hypertrophy in 5 participants. Status unknown.

Timeline

1 November 2020

Primary endpoint
30 November 2021

30 November 2022

Quick facts

Lead sponsor	Ramsay Générale de Santé
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	5
Start date	1 November 2020
Primary completion	30 November 2021
Estimated completion	30 November 2022
Sites	1 location across France

Drugs / interventions tested

Robot Breast reduction surgery

Conditions studied

Breast Hypertrophy — all drugs for Breast Hypertrophy →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

18 and older, female only, with Breast Hypertrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast enlargement reductions are frequent interventions. One of the main issue associated with this surgery remains the ransom scar, wide at the periareolar level, vertical at the subareolar level and in the submammary groove. The expected result is to achieve a reduction in breast enlargement with no visible scar using Da Da Vinci Xi robot.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Hypertrophy

Currently open trials in the same condition.

NCT05233891 — Validation of Scales in Reconstructive Breast Surgery · recruiting

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04597515 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 22 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04597515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing